Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLET for Ocular Surface Disease
NCT01123044Phase 3Unknown
- Sponsor
- Ministry of Health Malaysia
- Start
- Aug 2011
- Primary completion
- Jun 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of ex vivo reconstructed autologous human corneal epithelium containing stem cells in limbal stem cell deficiency (LSCD), sponsored by Ministry of Health Malaysia. Status: unknown.
02
Drugs
ex vivo reconstructed autologous human corneal epithelium containing stem cells
03
Conditions
limbal stem cell deficiency (LSCD)
Beyond the preview
Go deeper on NCT01123044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01123044.